|
Volumn 36, Issue 3, 2006, Pages 325-330
|
Intranasal steroid reduces exhaled bronchial cysteinyl leukotrienes in allergic patients
|
Author keywords
Asthma; Exhaled breath condensate; Intranasal steroids; Leukotrienes; Rhinitis
|
Indexed keywords
FLUTICASONE PROPIONATE;
LEUKOTRIENE C4;
LEUKOTRIENE D4;
LEUKOTRIENE E4;
PEPTIDOLEUKOTRIENE;
ADULT;
ALLERGIC RHINITIS;
ARTICLE;
ASTHMA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
ENZYME IMMUNOASSAY;
EXPIRED AIR;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RHINITIS;
SALIVA ANALYSIS;
SPIROMETRY;
TREATMENT OUTCOME;
ADMINISTRATION, INTRANASAL;
ADULT;
ANDROSTADIENES;
ANTI-INFLAMMATORY AGENTS;
ASTHMA;
BIOLOGICAL MARKERS;
BREATH TESTS;
BRONCHI;
CYSTEINE;
DOUBLE-BLIND METHOD;
FEMALE;
FORCED EXPIRATORY VOLUME;
HUMANS;
LEUKOTRIENES;
MALE;
RHINITIS, ALLERGIC, SEASONAL;
VITAL CAPACITY;
|
EID: 33644809868
PISSN: 09547894
EISSN: 13652222
Source Type: Journal
DOI: 10.1111/j.1365-2222.2006.02449.x Document Type: Article |
Times cited : (20)
|
References (36)
|